PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril
Не применимо
Завершено
NCT04656847
| Заболевание | Coronary Artery Disease, Myocardial Infarction, Arterial Hypertension |
|---|
| Фаза | Не применимо |
|---|
| Спонсор | Servier Russia |
|---|
| Статус | Завершено |
|---|
| Участники | 504 участн. |
|---|
| Вмешательство | in daily everyday routine practice |
|---|
| Дата начала | 1.03.2021 |
|---|
| Дата завершения | 5.10.2021 |
|---|
| Публикация результатов | 1.11.2024 |
|---|
Кратко
This non-interventional, ambispective study was aimed at evaluating the effectiveness, safety, and tolerability of bisoprolol and perindopril SPC in previous myocardial infarction patients with HTN and CAD treated with the drug for 12 weeks in the daily clinical practice. SPC will be used according to the approved instruction for medical use of the medicine. This is a multi-centre, observational, incomparative, ambispective study, which will retrospectively and prospectively collect clinical variables and socio-demographic data from medical records of patients with HTN and previous MI initiated with bisoprolol/perindopril SPC in real life settings.
Antihypertensive Effectiveness (SBP and DBP) of Bisoprolol/Perindopril SPC in CAD Patients With Previous MI and HTN at Week 12 of Treatment Compared With Baseline
3 months · mm Hg
| CAD Patients With Previous MI and HTN | -24.92 ± 16.43 mm Hg |
|---|
| CAD Patients With Previous MI and HTN | -12.21 ± 11.03 mm Hg |
|---|
Открыть в BENITIONS
Открыть на ClinicalTrials.gov
Все исследования
Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.